» Articles » PMID: 9060685

Role of CCR5 in Infection of Primary Macrophages and Lymphocytes by Macrophage-tropic Strains of Human Immunodeficiency Virus: Resistance to Patient-derived and Prototype Isolates Resulting from the Delta Ccr5 Mutation

Overview
Journal J Virol
Date 1997 Apr 1
PMID 9060685
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

The alpha-chemokine receptor fusin (CXCR-4) and beta-chemokine receptor CCR5 serve as entry cofactors for T-cell (T)-tropic and macrophage (M)-tropic human immunodeficiency virus type 1 (HIV-1) strains, respectively, when expressed with CD4 in otherwise nonpermissive cells. Some M-tropic and dual-tropic strains can also utilize other beta-chemokine receptors, such as CCR2b and CCR3. A mutation of CCR5 (delta ccr5) was recently found to be common in certain populations and appears to confer protection against HIV-1 in vivo. Here, we show that this mutation results in a protein that is expressed intracellularly but not on the cell surface. Primary CD4 T cells from delta ccr5 homozygous individuals were highly resistant to infection with prototype M-tropic HIV-1 strains, including an isolate (YU-2) that uses CCR5 and CCR3, but were permissive for both a T-tropic strain (3B) and a dual-tropic variant (89.6) that uses CXCR-4, CCR5, CCR3, or CCR2b. These cells were also resistant to M-tropic patient isolates but were readily infected by T-tropic patient isolates. Primary macrophages from delta ccr5 homozygous individuals were also resistant to infection with M-tropic strains, including YU-2, but the dual-tropic strain 89.6 was able to replicate in them even though macrophages are highly resistant to CXCR-4-dependent T-tropic isolates. These data show that CCR5 is the essential cofactor for infection of both primary macrophages and T lymphocytes by most M-tropic strains of HIV-1. They also suggest that CCR3 does not function for HIV-1 entry in primary lymphocytes or macrophages, but that a molecule(s) other than CCR5 can support entry into macrophages by certain virus isolates. These studies further define the cellular basis for the resistance to HIV-1 infection of individuals lacking functional CCR5.

Citing Articles

Ectopic USP15 expression inhibits HIV-1 transcription involving changes in YY1 deubiquitination and stability.

Rezaei S, Timani K, Liu Y, He J Front Cell Infect Microbiol. 2024; 14():1371655.

PMID: 39624264 PMC: 11609158. DOI: 10.3389/fcimb.2024.1371655.


Identification of novel genes involved in apoptosis of HIV-infected macrophages using unbiased genome-wide screening.

Dong S, Vizeacoumar F, Bhanumathy K, Alli N, Gonzalez-Lopez C, Gajanayaka N BMC Infect Dis. 2021; 21(1):655.

PMID: 34233649 PMC: 8261936. DOI: 10.1186/s12879-021-06346-7.


Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120.

Rios S, Colon Saez J, Quesada O, Figueroa K, Lasalde Dominicci J J Biol Chem. 2021; 296:100618.

PMID: 33811859 PMC: 8102909. DOI: 10.1016/j.jbc.2021.100618.


Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.

Rautenbach A, Williams A Int J Mol Sci. 2020; 21(4).

PMID: 32098198 PMC: 7073144. DOI: 10.3390/ijms21041472.


Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

Arendt V, Amand M, Iserentant G, Lemaire M, Masquelier C, Ndayisaba G J Int AIDS Soc. 2019; 22(9):e25384.

PMID: 31486251 PMC: 6727025. DOI: 10.1002/jia2.25384.


References
1.
Freedman A, Gibson F, Fleming S, Spry C, Griffin G . Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J Exp Med. 1991; 174(6):1661-4. PMC: 2119059. DOI: 10.1084/jem.174.6.1661. View

2.
Connor R, Paxton W, Sheridan K, Koup R . Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1. J Virol. 1996; 70(12):8758-64. PMC: 190972. DOI: 10.1128/JVI.70.12.8758-8764.1996. View

3.
Kuiken C, de Jong J, Baan E, Keulen W, Tersmette M, Goudsmit J . Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol. 1992; 66(7):4622-7. PMC: 241280. DOI: 10.1128/JVI.66.7.4622-4627.1992. View

4.
Collman R, Balliet J, Gregory S, Friedman H, Kolson D, NATHANSON N . An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol. 1992; 66(12):7517-21. PMC: 240461. DOI: 10.1128/JVI.66.12.7517-7521.1992. View

5.
Koot M, Keet I, Vos A, de Goede R, Roos M, Coutinho R . Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med. 1993; 118(9):681-8. DOI: 10.7326/0003-4819-118-9-199305010-00004. View